These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 15899786

  • 1. Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity.
    Kim M, Yan Y, Kortum RL, Stoeger SM, Sgagias MK, Lee K, Lewis RE, Cowan KH.
    Cancer Res; 2005 May 15; 65(10):3986-92. PubMed ID: 15899786
    [Abstract] [Full Text] [Related]

  • 2. Characterization of kinase suppressor of Ras-1 expression and anticancer drug sensitivity in human cancer cell lines.
    Stoeger SM, Cowan KH.
    Cancer Chemother Pharmacol; 2009 Apr 15; 63(5):807-18. PubMed ID: 18661133
    [Abstract] [Full Text] [Related]

  • 3. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R, Piperdi S, Gorlick R.
    Clin Cancer Res; 2008 Oct 15; 14(20):6396-404. PubMed ID: 18927278
    [Abstract] [Full Text] [Related]

  • 4. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT, Klein PJ, Wentz SC, Zeni A, Menze A, Schmidt CM.
    J Pharmacol Exp Ther; 2009 Jun 15; 329(3):1063-70. PubMed ID: 19258520
    [Abstract] [Full Text] [Related]

  • 5. Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice.
    Lozano J, Xing R, Cai Z, Jensen HL, Trempus C, Mark W, Cannon R, Kolesnick R.
    Cancer Res; 2003 Jul 15; 63(14):4232-8. PubMed ID: 12874031
    [Abstract] [Full Text] [Related]

  • 6. Role of ERK activation in cisplatin-induced apoptosis in A172 human glioma cells.
    Choi BK, Choi CH, Oh HL, Kim YK.
    Neurotoxicology; 2004 Dec 15; 25(6):915-24. PubMed ID: 15474610
    [Abstract] [Full Text] [Related]

  • 7. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B.
    J Endocrinol; 2005 Jun 15; 185(3):577-92. PubMed ID: 15930183
    [Abstract] [Full Text] [Related]

  • 8. Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells.
    Ahmed KM, Dong S, Fan M, Li JJ.
    Mol Cancer Res; 2006 Dec 15; 4(12):945-55. PubMed ID: 17189385
    [Abstract] [Full Text] [Related]

  • 9. CK2 Is a component of the KSR1 scaffold complex that contributes to Raf kinase activation.
    Ritt DA, Zhou M, Conrads TP, Veenstra TD, Copeland TD, Morrison DK.
    Curr Biol; 2007 Jan 23; 17(2):179-84. PubMed ID: 17174095
    [Abstract] [Full Text] [Related]

  • 10. Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance.
    Brozovic A, Osmak M.
    Cancer Lett; 2007 Jun 18; 251(1):1-16. PubMed ID: 17125914
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of peripheral benzodiazepine receptor ligand-induced apoptosis and cell cycle arrest of esophageal cancer cells by simultaneous inhibition of MAPK/ERK kinase.
    Sutter AP, Maaser K, Gerst B, Krahn A, Zeitz M, Scherübl H.
    Biochem Pharmacol; 2004 May 01; 67(9):1701-10. PubMed ID: 15081869
    [Abstract] [Full Text] [Related]

  • 12. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY, Chen CJ.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):49-60. PubMed ID: 17341418
    [Abstract] [Full Text] [Related]

  • 13. Activation of extracellular signal-regulated kinase during silibinin-protected, isoproterenol-induced apoptosis in rat cardiac myocytes is tyrosine kinase pathway-mediated and protein kinase C-dependent.
    Zhou B, Wu LJ, Tashiro S, Onodera S, Uchiumi F, Ikejima T.
    Acta Pharmacol Sin; 2007 Jun 01; 28(6):803-10. PubMed ID: 17506939
    [Abstract] [Full Text] [Related]

  • 14. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
    Yu W, Shun MC, Anderson K, Chen H, Sanders BG, Kline K.
    Apoptosis; 2006 Oct 01; 11(10):1813-23. PubMed ID: 16850165
    [Abstract] [Full Text] [Related]

  • 15. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
    Lee M.
    Biochem Biophys Res Commun; 2006 Nov 17; 350(2):450-6. PubMed ID: 17010316
    [Abstract] [Full Text] [Related]

  • 16. Peroxiredoxin I plays a protective role against cisplatin cytotoxicity through mitogen activated kinase signals.
    Ma D, Warabi E, Yanagawa T, Kimura S, Harada H, Yamagata K, Ishii T.
    Oral Oncol; 2009 Dec 17; 45(12):1037-43. PubMed ID: 19692293
    [Abstract] [Full Text] [Related]

  • 17. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
    Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadwala M, Dubinett SM.
    Cancer Res; 2005 Jul 15; 65(14):6275-81. PubMed ID: 16024629
    [Abstract] [Full Text] [Related]

  • 18. ERK signaling pathway is differentially involved in erythroid differentiation of K562 cells depending on time and the inducing agent.
    Woessmann W, Zwanzger D, Borkhardt A.
    Cell Biol Int; 2004 Jul 15; 28(5):403-10. PubMed ID: 15193284
    [Abstract] [Full Text] [Related]

  • 19. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.
    Ma Y, Yu WD, Kong RX, Trump DL, Johnson CS.
    Cancer Res; 2006 Aug 15; 66(16):8131-8. PubMed ID: 16912191
    [Abstract] [Full Text] [Related]

  • 20. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C, Marampon F, Scoglio A, Mauro A, Giacinti C, De Cesaris P, Zani BM.
    Mol Cancer; 2005 Dec 13; 4():41. PubMed ID: 16351709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.